These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8363602)

  • 1. Inhibition of ret tyrosine kinase activity by herbimycin A.
    Taniguchi M; Uehara Y; Matsuyama M; Takahashi M
    Biochem Biophys Res Commun; 1993 Aug; 195(1):208-14. PubMed ID: 8363602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase activity of the ret proto-oncogene products in vitro.
    Miyazaki K; Asai N; Iwashita T; Taniguchi M; Isomura T; Funahashi H; Takagi H; Matsuyama M; Takahashi M
    Biochem Biophys Res Commun; 1993 Jun; 193(2):565-70. PubMed ID: 7685595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors.
    Cohen MS; Hussain HB; Moley JF
    Surgery; 2002 Dec; 132(6):960-6; discussion 966-7. PubMed ID: 12490842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
    Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
    Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.
    Fukazawa H; Li PM; Yamamoto C; Murakami Y; Mizuno S; Uehara Y
    Biochem Pharmacol; 1991 Oct; 42(9):1661-71. PubMed ID: 1656993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
    Faris M; Gaskin F; Parsons JT; Fu SM
    J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A.
    Uehara Y; Murakami Y; Mizuno S; Kawai S
    Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the protein tyrosine kinase inhibitor, herbimycin A, on prolactin gene expression in GH3 and 235-1 pituitary tumor cells.
    Billis WM; White BA
    Biochim Biophys Acta; 1997 Aug; 1358(1):31-8. PubMed ID: 9296518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.
    Graber M; June CH; Samelson LE; Weiss A
    Int Immunol; 1992 Nov; 4(11):1201-10. PubMed ID: 1472473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit.
    Mahon TM; O'Neill LA
    J Biol Chem; 1995 Dec; 270(48):28557-64. PubMed ID: 7499370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds.
    Uehara Y; Fukazawa H; Murakami Y; Mizuno S
    Biochem Biophys Res Commun; 1989 Sep; 163(2):803-9. PubMed ID: 2783121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase.
    Xu X; Chong AS
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):527-32. PubMed ID: 8809042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
    Murakami Y; Fukazawa H; Mizuno S; Uehara Y
    Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
    Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protein tyrosine phosphorylation in etoposide-induced apoptosis and NF-kappa B activation.
    Usami I; Kubota M; Bessho R; Kataoka A; Koishi S; Watanabe K; Sawada M; Lin YW; Akiyama Y; Furusho K
    Biochem Pharmacol; 1998 Jan; 55(2):185-91. PubMed ID: 9448741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbimycin A suppresses NF-kappa B activation and tyrosine phosphorylation of JAK2 and the subsequent induction of nitric oxide synthase in C6 glioma cells.
    Nishiya T; Uehara T; Nomura Y
    FEBS Lett; 1995 Sep; 371(3):333-6. PubMed ID: 7556623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor.
    Zhao M; Kiyoi H; Yamamoto Y; Ito M; Towatari M; Omura S; Kitamura T; Ueda R; Saito H; Naoe T
    Leukemia; 2000 Mar; 14(3):374-8. PubMed ID: 10720129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cells.
    Makishima M; Yamamoto-Yamaguchi Y; Honma Y
    Biochim Biophys Acta; 1995 Dec; 1272(3):199-205. PubMed ID: 8541353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
    Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
    Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.
    Sepp-Lorenzino L; Ma Z; Lebwohl DE; Vinitsky A; Rosen N
    J Biol Chem; 1995 Jul; 270(28):16580-7. PubMed ID: 7622464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.